Researchers have made a breakthrough in the fight against pancreatic cancer with an experimental vaccine that shows promise in preventing recurrence. A Phase 1 study found that most patients who received the vaccine developed an immune response against cancer-causing cells, which could help prevent relapse.
The vaccine is based on peptides and proteins that stimulate the immune system to attack cancer cells in lymph nodes. Although further trials are needed to confirm its effectiveness, pancreatic oncologist Shivan Sivakumar notes that the results suggest vaccination may play a role in preventing recurrence.
Developed by Elicio Therapeutics, the off-the-shelf vaccine makes it easy for patients to access, and its potential is significant. With this breakthrough, researchers aim to give patients more options against this often deadly disease.
Source: https://www.statnews.com/2025/08/11/cancer-vaccine-prevent-pancreatic-relapse